glp-1 employer coverage news october 2025 Perspectives from Employers on the Costs and Issues Associated with Covering Agonists for Weight Loss Medicare GLP-1 Drug Coverage -

This increase is likely to continue due to their significant benefits in weight management and cardiorenal protection observed in individuals with type 2 diabetes and the general obese population, Shao said, noting that urgent studies are needed to better elucidate the benefits and risks of the GLP-1 and SGLT2 drug classes in T1D

But in the absence of science, its hard to recommend these medications [for ADHD], especially without safety reviews in these patients. Is it dangerous for people with ADHD to take GLP-1s

Slivka A, Cohen G

acknowledges support from the Spanish Severo Ochoa Program (SEV-2011-00067)

Why accept 15% weight loss when 25% might eventually be on offer